» Articles » PMID: 36221105

Exosomes: Mediators Regulating the Phenotypic Transition of Vascular Smooth Muscle Cells in Atherosclerosis

Overview
Publisher Biomed Central
Date 2022 Oct 11
PMID 36221105
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular disease is one of the leading causes of human mortality worldwide, mainly due to atherosclerosis (AS), and the phenotypic transition of vascular smooth muscle cells (VSMCs) is a key event in the development of AS. Exosomes contain a variety of specific nucleic acids and proteins that mediate intercellular communication. The role of exosomes in AS has attracted attention. This review uses the VSMC phenotypic transition in AS as the entry point, introduces the effect of exosomes on AS from different perspectives, and discusses the status quo, deficiencies, and potential future directions in this field to provide new ideas for clinical research and treatment of AS. Video Abstract.

Citing Articles

Exosome miR-199a-5p modulated vascular remodeling and inflammatory infiltration of Takayasu's arteritis.

Guo S, Li J, Pang S, Li J, Tian X Arthritis Res Ther. 2025; 27(1):11.

PMID: 39833857 PMC: 11744942. DOI: 10.1186/s13075-025-03475-1.


The Physiological Functions and Therapeutic Potential of Hypoxia-Inducible Factor-1α in Vascular Calcification.

Zhang Z, Wang D, Xu R, Li X, Wang Z, Zhang Y Biomolecules. 2025; 14(12.

PMID: 39766299 PMC: 11674127. DOI: 10.3390/biom14121592.


Enhanced secretion of promyogenic exosomes by quiescent muscle cells.

Devan P, Ghosh A, Rao T P, Raychaudhuri S, Adicherla H, Devanshi H Front Cell Dev Biol. 2024; 12:1381357.

PMID: 39108837 PMC: 11301339. DOI: 10.3389/fcell.2024.1381357.


The Role of Macrophages in Atherosclerosis: Participants and Therapists.

Liu X, Pang S, Jiang Y, Wang L, Liu Y Cardiovasc Drugs Ther. 2023; .

PMID: 37864633 DOI: 10.1007/s10557-023-07513-5.


Removing the stumbling block of exosome applications in clinical and translational medicine: expand production and improve accuracy.

Han L, Zhao Z, He C, Li J, Li X, Lu M Stem Cell Res Ther. 2023; 14(1):57.

PMID: 37005658 PMC: 10068172. DOI: 10.1186/s13287-023-03288-6.

References
1.
Chistiakov D, Orekhov A, Bobryshev Y . Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf). 2015; 214(1):33-50. DOI: 10.1111/apha.12466. View

2.
Kibria G, Ramos E, Wan Y, Gius D, Liu H . Exosomes as a Drug Delivery System in Cancer Therapy: Potential and Challenges. Mol Pharm. 2018; 15(9):3625-3633. PMC: 6546090. DOI: 10.1021/acs.molpharmaceut.8b00277. View

3.
Wu C, Huang C . MicroRNA-147 inhibits myocardial inflammation and apoptosis following myocardial infarction via targeting HIPK2. Eur Rev Med Pharmacol Sci. 2020; 24(11):6279-6287. DOI: 10.26355/eurrev_202006_21526. View

4.
Zhang Z, Yi D, Zhou J, Zheng Y, Gao Z, Hu X . Exosomal LINC01005 derived from oxidized low-density lipoprotein-treated endothelial cells regulates vascular smooth muscle cell phenotypic switch. Biofactors. 2020; 46(5):743-753. DOI: 10.1002/biof.1665. View

5.
Qu C, Liu X, Guo Y, Fo Y, Chen X, Zhou J . MiR-128-3p inhibits vascular smooth muscle cell proliferation and migration by repressing FOXO4/MMP9 signaling pathway. Mol Med. 2020; 26(1):116. PMC: 7687681. DOI: 10.1186/s10020-020-00242-7. View